New Head of Analytics to Help Healthcare Target Interventions for Better Outcomes

MedeAnalyticsA new head of analytics at the UK arm of MedeAnalytics, a pioneer in health analytics, is to help healthcare planners and frontline staff understand which patients, across their entire local population, are at risk of specific adverse events and what interventions will work for individual patients as a means of prevention.

Paul Molyneux, who has held posts at the Care Quality Commission (CQC), Cerner and Dr Foster, has joined a rapidly growing team of world-class specialists at MedeAnalytics in the UK. Working with areas like Hertfordshire, the team has helped health and social care organisations overcome information governance obstacles to create a joined-up health economy. The result is that for the first time, organisations can safely link and unlock their data for use across health and social care whilst still securely maintaining patient privacy.

Molyneux, who was once part of the Healthcare Commission team that uncovered statistical outliers related to the Mid Staffordshire scandal, will now work closely with clinical and epidemiological colleagues at MedeAnalytics and throughout health and care.

He will help to develop risk models that predict which interventions will prove successful for specific patients and that will allow resources to be targeted where they will work across populations.

Commenting on his appointment Molyneux said: "If you can measure something, you can manage it. MedeAnalytics has become the first to solve major governance obstacles to enable the safe sharing and use of information between authorised users across different care settings. I look forward to working with customers throughout the UK to help them unleash the power of that information by predicting where and when, across their health economy, they can have the maximum impact for patients. Crucially, this is about getting research onto the shop floor and into practice, in order to improve outcomes."

Molyneux's new role at MedeAnalytics follows a series of high profile appointments in the UK for the company, including Professor Simon Jones, former chief statistician at Dr Foster, and Dr Mark Davies, the former medical director at the Health and Social Care Information Centre.

Wayne Parslow, UK general manager at MedeAnalytics, said: "Having the right people in place with the right tools to respond to real NHS and healthcare challenges is crucial. Paul will work closely with Professor Jones and Dr Davies to hone new ideas on predictive analytics, with real clinical understanding, so that we can help local health economies deliver services that are truly focussed on achieving the most for individual patients across their population. This will herald a new era of targeted and more efficient health and social care.

"Combining these thought leaders, with the right technology, and working in collaboration with those on the frontline, will allow the NHS and social care to not only understand which patients are at risk, but where, when and how they can successfully intervene."

About MedeAnalytics
MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare - how to use the immense amount of patient data collected along the care continuum to deliver cost-effective care and promote a healthier population. Its analytics platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics' cloud-based tools have been used to uncover business insights for nearly 1,000 healthcare organizations across the United States and United Kingdom. The company has also been named one of Modern Healthcare's top 100 Best Places to Work in Healthcare for 2014.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...